Table 3.
SIB-IMRT group (%) | Non-SIB-IMRT group (%) | p value | |
---|---|---|---|
Any grade II acute toxicity during CRT (For total 151 patients) |
25(30.1%) | 27(39.1%) | 0.217 |
Leukopenia | 10(12.0%) | 9(13.2%) | 0.827 |
Proctitis | 12(14.5%) | 13(19.1%) | 0.443 |
Radiodermatitis | 2(2.4%) | 4(5.9%) | 0.277 |
Anemia | 3(3.6%) | 1(1.5%) | 0.414 |
Diarrhea | 1(1.2%) | 5(7.4%) | 0.054 |
Fatigue | 0 | 1(1.5%) | 0.268 |
Flatulence | 1(1.2%) | 0 | 0.364 |
Postoperative complication (For total 104 patients) | 12(21.8%) | 6(12.2%) | 0.198 |
Small-bowel obstruction | 4(7.3%) | 2(4.1%) | 0.486 |
Abdominal wound infections | 2(3.6%) | 0 | 0.178 |
Perineal wound infections | 2(3.6%) | 0 | 0.178 |
Anastomotic leakage | 1(1.8%) | 0 | 0.343 |
Urological | 1(1.8%) | 3(6.0%) | 0.255 |
Bleeding | 1(1.8%) | 1(2.0%) | 0.934 |
Electrolyte disturbance | 1(1.8%) | 0 | 0.343 |
CRT, Chemoradiotherapy.